False-Positive FDG PET Uptake−the Role of PET/CT

[1]  P. Wust,et al.  Comparison of CT, MRI and FDG-PET in response prediction of patients with locally advanced rectal cancer after multimodal preoperative therapy: Is there a benefit in using functional imaging? , 2005, European Radiology.

[2]  T. Beyer,et al.  Optimized intravenous contrast administration for diagnostic whole-body 18F-FDG PET/CT. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[3]  S. Schmidt,et al.  Occult lung infarction may induce false interpretation of 18F-FDG PET in primary staging of pulmonary malignancies , 2005, European Journal of Nuclear Medicine and Molecular Imaging.

[4]  A. Figer,et al.  Detection of recurrence in patients with rectal cancer: PET/CT after abdominoperineal or anterior resection. , 2004, Radiology.

[5]  W. Martin,et al.  PET and PET-CT for evaluation of colorectal carcinoma. , 2004, Seminars in nuclear medicine.

[6]  Thomas Beyer,et al.  Positron emission tomography/computed tomography--imaging protocols, artifacts, and pitfalls. , 2004, Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging.

[7]  N. Avril.  GLUT1 expression in tissue and (18)F-FDG uptake. , 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[8]  Kyung-Ja Cho,et al.  Overexpression of Glut1 in lymphoid follicles correlates with false-positive (18)F-FDG PET results in lung cancer staging. , 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[9]  D. Grisaru,et al.  Normal and abnormal 18F-FDG endometrial and ovarian uptake in pre- and postmenopausal patients: assessment by PET/CT. , 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[10]  M. Tomita,et al.  A case of non-small cell lung cancer with false-positive staging by positron emission tomography. , 2003, Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia.

[11]  Mithat Gonen,et al.  Patterns of (18)F-FDG uptake in adipose tissue and muscle: a potential source of false-positives for PET. , 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[12]  R. Wahl,et al.  Direct Comparison of 18F-FDG PET and PET/CT in Patients with Colorectal Carcinoma , 2003 .

[13]  Y. Tsushima,et al.  High [18F] 2-fluoro-2-deoxy-d-glucose (FDG) uptake of adrenocortical adenoma showing subclinical Cushing's syndrome , 2003, Annals of nuclear medicine.

[14]  Cyrill Burger,et al.  Impact of metallic dental implants on CT-based attenuation correction in a combined PET/CT scanner , 2003, European Radiology.

[15]  I. Fogelman,et al.  F-18 FDG Positron Emission Tomography and Benign Fractures , 2003, Clinical nuclear medicine.

[16]  Richard L Wahl,et al.  Uptake in supraclavicular area fat ("USA-Fat"): description on 18F-FDG PET/CT. , 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[17]  Yuji Nakamoto,et al.  Respiratory motion artifacts on PET emission images obtained using CT attenuation correction on PET-CT , 2003, European Journal of Nuclear Medicine and Molecular Imaging.

[18]  Gerald Antoch,et al.  Whole-body positron emission tomography-CT: optimized CT using oral and IV contrast materials. , 2002, AJR. American journal of roentgenology.

[19]  Gerald Antoch,et al.  Focal tracer uptake: a potential artifact in contrast-enhanced dual-modality PET/CT scans. , 2002, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[20]  J. Bading,et al.  Incidental colonic fluorodeoxyglucose uptake: correlation with colonoscopic and histopathologic findings. , 2002, Radiology.

[21]  A. Buck,et al.  Brown adipose tissue: a factor to consider in symmetrical tracer uptake in the neck and upper chest region , 2002, European Journal of Nuclear Medicine and Molecular Imaging.

[22]  Cyrill Burger,et al.  Recurrent laryngeal nerve palsy in patients with lung cancer: detection with PET-CT image fusion -- report of six cases. , 2002, Radiology.

[23]  E. Lin,et al.  Adrenal hyperplasia in Cushing's syndrome demonstrated by FDG positron emission tomographic imaging. , 2002, Clinical nuclear medicine.

[24]  Cyrill Burger,et al.  PET-CT image co-registration in the thorax: influence of respiration , 2002, European Journal of Nuclear Medicine and Molecular Imaging.

[25]  A. Alavi,et al.  18F-FDG PET in characterizing adrenal lesions detected on CT or MRI. , 2001, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[26]  M. Cohen,et al.  Risk of malignancy in thyroid incidentalomas identified by fluorodeoxyglucose-positron emission tomography. , 2001, Surgery.

[27]  G. V. von Schulthess,et al.  Joint accumulations of FDG in whole body PET scans , 2001, Nuklearmedizin.

[28]  E. Nitzsche,et al.  Increased metabolic activity in the thymus gland studied with 18F-FDG PET: age dependency and frequency after chemotherapy. , 2001, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[29]  Michael N. Maisey,et al.  Normal variants, artefacts and interpretative pitfalls in PET imaging with 18-fluoro-2-deoxyglucose and carbon-11 methionine , 1999, European Journal of Nuclear Medicine.

[30]  B. Alfano,et al.  Imaging of adrenal tumors using FDG PET: comparison of benign and malignant lesions. , 1999, AJR. American journal of roentgenology.

[31]  S. Yasuda,et al.  Increased FDG uptake in the wall of the right atrium in people who participated in a cancer screening program with whole-body PET , 1999, Annals of nuclear medicine.

[32]  S. Yasuda,et al.  Chronic thyroiditis: diffuse uptake of FDG at PET. , 1998, Radiology.

[33]  S. Barrington,et al.  Speech-related visualization of laryngeal muscles with fluorine-18-FDG. , 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[34]  H. Alibazoglu,et al.  Normal thymic uptake of FDG on PET imaging. , 1996, Clinical nuclear medicine.

[35]  M. J. Fusselman,et al.  Benign versus malignant intraosseous lesions: discrimination by means of PET with 2-[F-18]fluoro-2-deoxy-D-glucose. , 1996, Radiology.

[36]  Ren-Shyan Liu,et al.  Use of fluorine-18 fluorodeoxyglucose positron emission tomography in the detection of thymoma: A preliminary report , 1995, European Journal of Nuclear Medicine.

[37]  J. Himms-Hagen,et al.  Impaired thermogenesis and brown fat in obesity. , 1984, Canadian journal of surgery. Journal canadien de chirurgie.

[38]  Gerald Antoch,et al.  Detection of residual tumor after radiofrequency ablation of liver metastasis with dual-modality PET/CT: initial results , 2005, European Radiology.

[39]  Richard L Wahl,et al.  Why nearly all PET of abdominal and pelvic cancers will be performed as PET/CT. , 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[40]  Thomas Beyer,et al.  Acquisition protocol considerations for combined PET/CT imaging. , 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[41]  Thomas Beyer,et al.  To enhance or not to enhance? 18F-FDG and CT contrast agents in dual-modality 18F-FDG PET/CT. , 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[42]  R L Wahl,et al.  Pitfalls in oncologic diagnosis with FDG PET imaging: physiologic and benign variants. , 1999, Radiographics : a review publication of the Radiological Society of North America, Inc.

[43]  R. Wahl,et al.  Preclinical and clinical studies of bone marrow uptake of fluorine-1-fluorodeoxyglucose with or without granulocyte colony-stimulating factor during chemotherapy. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[44]  R. Wahl,et al.  Uptake of 2-deoxy-2-[18F]fluoro-d-glucose in the normal testis: Retrospective PET study and animal experiment , 1997, Annals of nuclear medicine.